From: Personalized Disease Prevention (PDP): study protocol for a cluster-randomized clinical trial
Preventive service | Target | |
---|---|---|
Cancer screenings | ||
 1 | Breast cancera | Every 2 years |
 2 | Cervical cancer | Co-testing (hrHPV testing plus cytology) every 5 years |
 3 | Colorectal cancer | Decennial colonoscopyb |
 4 | Lung cancer | Every 1 year |
Cardiovascular disease reduction | ||
 5 | Abdominal aortic aneurysm screening | Once |
 6 | Blood pressure controlc | 130/80 mmHg |
 7 | Lipids controlc | 30% (low-intensity statins) or 50% (moderate-high intensity statins) reduction in LDLd |
Diabetes control | ||
 8 | Diabetes controlc | If baseline 7.0–7.9%, 8.0–8.9%, 9.0–10.9%, ≥11.0%: HbA1c = 1 point reduction, 7%, 2 point reduction, 9%, respectively |
Healthy lifestylee | ||
 9 | Alcohol misusec | ≤1 drink/day (female) or ≤2 drinks/day (male) |
 10 | Bariatric surgeryc,f | Mean of roux-en-Y gastric bypass and sleeve gastrectomy |
 11 | Healthy diet | Lowest quintile of risk based on NHANES cycles 2013–2014 through 2017–2018 |
 12 | Light exercise | 30 min per day |
 13 | Moderate-vigorous exercise | 150 min moderate or 75 min vigorous exercise per week, plus muscle strengthening exercise 2 days per week |
 14 | Tobacco cessationc | Quit smoking |
Vaccines | ||
 15 | Influenza vaccineg | Annual |
 16 | Pneumonia vaccineg | PPSV23 (1–2 doses based on ACIP guidelines) |
 17 | Tetanus vaccineg | Decennial |
 18 | Zoster vaccineg | Two doses of Shingrix |
Other | ||
 19 | Hepatitis C virus (HCV) testingg | Once |
 20 | HIV testingg | Once (low-risk individuals) or annual (high-risk individuals) |
 21 | Osteoporosis screening/falls preventiong | Once |
 22 | Testing for sexually transmitted infectionsg | Annual in high-risk individuals |